162 related articles for article (PubMed ID: 22488169)
1. Chemoaffinity capture of pre-targeted prostate cancer cells with magnetic beads.
Wu LY; Liu T; Hopkins MR; Davis WC; Berkman CE
Prostate; 2012 Oct; 72(14):1532-41. PubMed ID: 22488169
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric detection of prostate tumor cells using chemoaffinity labels.
Wu LY; Liu T; Grimm AL; Davis WC; Berkman CE
Prostate; 2011 Jan; 71(1):52-61. PubMed ID: 20632319
[TBL] [Abstract][Full Text] [Related]
3. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade.
Schmidt B; Anastasiadis AG; Seifert HH; Franke KH; Oya M; Ackermann R
Anticancer Res; 2003; 23(5A):3991-9. PubMed ID: 14666708
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer.
Paller CJ; Piana D; Eshleman JR; Riel S; Denmeade SR; Isaacsson Velho P; Rowe SP; Pomper MG; Antonarakis ES; Luo J; Eisenberger MA
Prostate; 2019 Oct; 79(14):1597-1603. PubMed ID: 31361358
[TBL] [Abstract][Full Text] [Related]
6. Concentration-dependent effects of dutasteride on prostate-specific membrane antigen (PSMA) expression and uptake of
Kranzbühler B; Salemi S; Umbricht CA; Deberle LM; Müller C; Burger IA; Hermanns T; Sulser T; Eberli D
Prostate; 2019 Sep; 79(12):1450-1456. PubMed ID: 31233227
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic-integrated patterned ITO immunosensor for rapid detection of prostate-specific membrane antigen biomarker in prostate cancer.
Seenivasan R; Singh CK; Warrick JW; Ahmad N; Gunasekaran S
Biosens Bioelectron; 2017 Sep; 95():160-167. PubMed ID: 28445813
[TBL] [Abstract][Full Text] [Related]
8. Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness.
Ghosh A; Wang X; Klein E; Heston WD
Cancer Res; 2005 Feb; 65(3):727-31. PubMed ID: 15705868
[TBL] [Abstract][Full Text] [Related]
9. Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells.
Lu NN; Xie M; Wang J; Lv SW; Yi JS; Dong WG; Huang WH
ACS Appl Mater Interfaces; 2015 Apr; 7(16):8817-26. PubMed ID: 25853336
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving
Kessel K; Seifert R; Weckesser M; Roll W; Humberg V; Schlack K; Bögemann M; Bernemann C; Rahbar K
Theranostics; 2020; 10(17):7645-7655. PubMed ID: 32685010
[No Abstract] [Full Text] [Related]
11. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells.
Kranzbühler B; Salemi S; Umbricht CA; Müller C; Burger IA; Sulser T; Eberli D
Prostate; 2018 Jul; 78(10):758-765. PubMed ID: 29633296
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.
Friedlander TW; Ngo VT; Dong H; Premasekharan G; Weinberg V; Doty S; Zhao Q; Gilbert EG; Ryan CJ; Chen WT; Paris PL
Int J Cancer; 2014 May; 134(10):2284-93. PubMed ID: 24166007
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer.
Nagaya N; Nagata M; Lu Y; Kanayama M; Hou Q; Hotta ZU; China T; Kitamura K; Matsushita K; Isotani S; Muto S; Sakamoto Y; Horie S
PLoS One; 2020; 15(1):e0226219. PubMed ID: 31986176
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
Sabile A; Louha M; Bonte E; Poussin K; Vona G; Mejean A; Chretien Y; Bougas L; Lacour B; Capron F; Roseto A; Bréchot C; Paterlini-Bréchot P
Am J Clin Pathol; 1999 Aug; 112(2):171-8. PubMed ID: 10439796
[TBL] [Abstract][Full Text] [Related]
16. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI
Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379
[TBL] [Abstract][Full Text] [Related]
17. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ
Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy.
Wright GL; Grob BM; Haley C; Grossman K; Newhall K; Petrylak D; Troyer J; Konchuba A; Schellhammer PF; Moriarty R
Urology; 1996 Aug; 48(2):326-34. PubMed ID: 8753752
[TBL] [Abstract][Full Text] [Related]
19. An integrated microfluidic chip for immunomagnetic detection and isolation of rare prostate cancer cells from blood.
Esmaeilsabzali H; Beischlag TV; Cox ME; Dechev N; Parameswaran AM; Park EJ
Biomed Microdevices; 2016 Feb; 18(1):22. PubMed ID: 26876965
[TBL] [Abstract][Full Text] [Related]
20. Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.
Liu T; Mendes DE; Berkman CE
Int J Oncol; 2014 Mar; 44(3):918-22. PubMed ID: 24424840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
